Cargando…

Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines

The DNA methyltransferase inhibitors azacytidine and decitabine represent archetypal drugs for epigenetic cancer therapy. To characterize the demethylating activity of azacytidine and decitabine we treated colon cancer and leukemic cells with both drugs and used array-based DNA methylation analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagemann, Sabine, Heil, Oliver, Lyko, Frank, Brueckner, Bodo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049766/ https://www.ncbi.nlm.nih.gov/pubmed/21408221 http://dx.doi.org/10.1371/journal.pone.0017388

Ejemplares similares

Antiproliferative Effects of DNA Methyltransferase 3B Depletion Are Not Associated with DNA Demethylation
por: Hagemann, Sabine, et al.
Publicado: (2012)

Comprehensive comparison between azacytidine and decitabine treatment in an acute myeloid leukemia cell line
por: Aumer, Tina, et al.
Publicado: (2022)

A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
por: Griffin, Patrick T., et al.
Publicado: (2016)

The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization
por: Massah, S., et al.
Publicado: (2020)

DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire
por: Nie, Jing, et al.
Publicado: (2016)

Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
por: Gu, Xiaorong, et al.
Publicado: (2020)

DNA demethylation in the PTEN gene promoter induced by 5-azacytidine activates PTEN expression in the MG-63 human osteosarcoma cell line
por: SONG, DEYE, et al.
Publicado: (2014)

Aerosol Azacytidine Inhibits Orthotopic Lung Cancers in Mice through Its DNA Demethylation and Gene Reactivation Effects
por: Qiu, Xuan, et al.
Publicado: (2014)

A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
por: Momparler, Richard L.
Publicado: (2012)

5-Azacytidine Improves the Osteogenic Differentiation Potential of Aged Human Adipose-Derived Mesenchymal Stem Cells by DNA Demethylation
por: Yan, Xueying, et al.
Publicado: (2014)

Demethylation by 5‐Azacytidine Results in the Expression of Hepatitis B Virus Surface Antigen in Transgenic Mice
por: Araki, Kimi, et al.
Publicado: (1989)

Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells
por: Öz, Simin, et al.
Publicado: (2014)

Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine
por: Hsieh, Yao-Yu, et al.
Publicado: (2016)

Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura
por: Wong, Joshua, et al.
Publicado: (2011)

Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation
por: Zhu, Zhipeng, et al.
Publicado: (2021)

Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature
por: Serravalle, Salvatore, et al.
Publicado: (2016)

Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine
por: Hsieh, Yao-Yu, et al.
Publicado: (2018)

Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells
por: Gerecke, Christian, et al.
Publicado: (2018)

5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells
por: Ren, Xiaoli, et al.
Publicado: (2018)

Epigenetic Regulation of Depot-Specific Gene Expression in Adipose Tissue
por: Gehrke, Sandra, et al.
Publicado: (2013)

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
por: Ramakrishnan, Swathi, et al.
Publicado: (2017)

Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)

mIDH-associated DNA hypermethylation in acute myeloid leukemia reflects differentiation blockage rather than inhibition of TET-mediated demethylation
por: Wiehle, Laura, et al.
Publicado: (2017)

Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation
por: Dong, Cheng, et al.
Publicado: (2014)

Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
por: Sajadian, Sahar Olsadat, et al.
Publicado: (2015)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation
por: Al-Romaih, Khaldoun, et al.
Publicado: (2007)

Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway
por: Jin, Yulong, et al.
Publicado: (2019)

DNA Methylation and Demethylation in Mammals
por: Chen, Zhao-xia, et al.
Publicado: (2011)

DNA methylation and demethylation dynamics
por: Neri, Francesco, et al.
Publicado: (2015)

Active DNA Demethylation in Plants
por: Parrilla-Doblas, Jara Teresa, et al.
Publicado: (2019)

Alterations of immune response of non-small cell lung cancer with Azacytidine
por: Wrangle, John, et al.
Publicado: (2013)

DNA Demethylation and USF Regulate the Meiosis-Specific Expression of the Mouse Miwi
por: Hou, Yu, et al.
Publicado: (2012)

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen
por: Schmutz, Maximilian, et al.
Publicado: (2023)

Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
por: Raj, Kavita, et al.
Publicado: (2006)

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells
por: Imanishi, Satoshi, et al.
Publicado: (2017)

DNA methylation patterns of Brachypodium distachyon chromosomes and their alteration by 5-azacytidine treatment
por: Borowska, Natalia, et al.
Publicado: (2011)

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
por: Tomar, Tushar, et al.
Publicado: (2016)

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023)

Neil DNA glycosylases promote substrate turnover by Tdg during DNA demethylation
por: Schomacher, Lars, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qvvnphb7ev8v6dc2ujr650booi